EGFR mutations prompt glioma cells to act as pericytes, dependent on BMX/SOX9, thereby stabilizing blood vessels and attracting immune cells via a glioma-to-pericyte transition 97 (Figure 5B). This evidence concerns the gene EGFR and central nervous system cancer.